Chemoinformaics analysis of Cyclopentane, 1-methyl-3-(1-methylethyl)-
Molecular Weight | 126.243 | nRot | 1 |
Heavy Atom Molecular Weight | 108.099 | nRig | 5 |
Exact Molecular Weight | 126.141 | nRing | 1 |
Solubility: LogS | -4.366 | nHRing | 0 |
Solubility: LogP | 3.944 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 27 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 9 | No. of Aromatic Carbocycles | 0 |
nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 1 |
No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 9 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
nHA | 0 | APOL | 27.0323 |
nHD | 0 | BPOL | 18.0577 |
QED | 0.506 |
Synth | 2.822 |
Natural Product Likeliness | 1.159 |
NR-PPAR-gamma | 0.003 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0.002 |
HIA | 0.003 |
CACO-2 | -4.33 |
MDCK | 0.0000196 |
BBB | 0.889 |
PPB | 0.927227 |
VDSS | 1.844 |
FU | 0.0597094 |
CYP1A2-inh | 0.637 |
CYP1A2-sub | 0.758 |
CYP2c19-inh | 0.176 |
CYP2c19-sub | 0.923 |
CYP2c9-inh | 0.441 |
CYP2c9-sub | 0.867 |
CYP2d6-inh | 0.01 |
CYP2d6-sub | 0.257 |
CYP3a4-inh | 0.079 |
CYP3a4-sub | 0.34 |
CL | 13.152 |
T12 | 0.22 |
hERG | 0.016 |
Ames | 0.01 |
ROA | 0.02 |
SkinSen | 0.481 |
Carcinogencity | 0.088 |
EI | 0.988 |
Respiratory | 0.292 |
NR-Aromatase | 0.003 |
Antiviral | No |
Prediction | 0.943591 |